29
Apr

After a quick march through the clinic, Novartis has won early FDA approval for the new “breakthrough” lung cancer drug ceritinib (or LDK378), which will now be launched as Zykadia.

…read more

Source: Novartis grabs early FDA approval of lung cancer drug Zykadia

    

0 No comments